MedTrace Logo

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn

NCT06675617 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-05-18

No results posted yet for this study

Summary

This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.

Conditions

  • Type B Aortic Dissection

Interventions

DEVICE

Allay Aortic Stent

Endovascular treatment of an aortic dissection

Sponsors & Collaborators

  • Intressa Vascular SA

    lead INDUSTRY

Principal Investigators

  • Wolf-Hans Eilenberg, MD, PhD, FEBVS · Medical University of Vienna

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-30
Primary Completion
2027-06-30
Completion
2031-06-30

Countries

  • Belgium
  • Bulgaria
  • France
  • Germany
  • Serbia
  • Uzbekistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06675617 on ClinicalTrials.gov